Differential Effects of Endocrine Therapy Type on Quality of Life in Older (≥70 Years) Women with Early-Stage Breast Cancer
This study suggests a differential impact by type of ET on distinct HRQoL domains experienced by older postmenopausal women. Furthermore, larger prospective clinical trials are necessary to inform treatment decisions for older ER-positive BC patients, considering patient preferences and understanding trade-offs between disease outcomes and HRQoL.
Authors
- Barry S. Rosenstein (ORCID: https://orcid.org/0000-0002-3149-3237)
- Erin Moshier (ORCID: https://orcid.org/0000-0002-8912-4709)
- Manjeet Chadha (ORCID: https://orcid.org/0000-0002-9194-1839)
- Keva Li
- Theresa Shao
Institutions
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1245/s10434-024-16482-4
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- European Commission